CA2691044A1 - Procedes et trousses pour tester l'efficacite de composes therapeutiques et d'autres therapies destines a des cellules et des tissus tumoraux dans une matrice tridimensionnelle - Google Patents

Procedes et trousses pour tester l'efficacite de composes therapeutiques et d'autres therapies destines a des cellules et des tissus tumoraux dans une matrice tridimensionnelle Download PDF

Info

Publication number
CA2691044A1
CA2691044A1 CA2691044A CA2691044A CA2691044A1 CA 2691044 A1 CA2691044 A1 CA 2691044A1 CA 2691044 A CA2691044 A CA 2691044A CA 2691044 A CA2691044 A CA 2691044A CA 2691044 A1 CA2691044 A1 CA 2691044A1
Authority
CA
Canada
Prior art keywords
cells
tissue
matrix
therapeutic compounds
sample
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2691044A
Other languages
English (en)
Other versions
CA2691044C (fr
Inventor
Penelope Costello
Warren Mcdonald
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2691044A1 publication Critical patent/CA2691044A1/fr
Application granted granted Critical
Publication of CA2691044C publication Critical patent/CA2691044C/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5082—Supracellular entities, e.g. tissue, organisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
CA2691044A 2007-06-13 2007-06-15 Procedes et trousses pour tester l'efficacite de composes therapeutiques et d'autres therapies destines a des cellules et des tissus tumoraux dans une matrice tridimensionnelle Active CA2691044C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US- 2004-11-17
US92912207P 2007-06-13 2007-06-13
PCT/IB2007/003494 WO2008012696A2 (fr) 2006-06-15 2007-06-15 Procédés et trousses pour tester l'efficacité de composés thérapeutiques et d'autres thérapies destinés à des cellules et des tissus tumoraux dans une matrice tridimensionnelle

Publications (2)

Publication Number Publication Date
CA2691044A1 true CA2691044A1 (fr) 2008-01-31
CA2691044C CA2691044C (fr) 2016-09-27

Family

ID=43607632

Family Applications (2)

Application Number Title Priority Date Filing Date
CA2698338A Expired - Fee Related CA2698338C (fr) 2007-06-13 2007-06-15 Matrices physiologiques tridimensionnelles pour test oncologique et procedes pour leur production et leur utilisation
CA2691044A Active CA2691044C (fr) 2007-06-13 2007-06-15 Procedes et trousses pour tester l'efficacite de composes therapeutiques et d'autres therapies destines a des cellules et des tissus tumoraux dans une matrice tridimensionnelle

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CA2698338A Expired - Fee Related CA2698338C (fr) 2007-06-13 2007-06-15 Matrices physiologiques tridimensionnelles pour test oncologique et procedes pour leur production et leur utilisation

Country Status (2)

Country Link
CA (2) CA2698338C (fr)
WO (3) WO2008012696A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102009038520B4 (de) * 2009-08-25 2012-07-05 Universität Rostock Verfahren und Vorrichtung zur Zellprobendiagnostik

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5032508A (en) * 1988-09-08 1991-07-16 Marrow-Tech, Inc. Three-dimensional cell and tissue culture system
SG47996A1 (en) * 1993-12-30 1998-04-17 Nitta Gelatin Kk Method for culturing animal cells under embedded conditions

Also Published As

Publication number Publication date
CA2698338C (fr) 2015-11-24
WO2008015581A3 (fr) 2011-02-24
CA2691044C (fr) 2016-09-27
WO2008015581A2 (fr) 2008-02-07
WO2008012696A2 (fr) 2008-01-31
WO2008012696A3 (fr) 2011-03-17
CA2698338A1 (fr) 2008-02-07
WO2008020337A2 (fr) 2008-02-21
WO2008020337A3 (fr) 2011-03-17

Similar Documents

Publication Publication Date Title
US12038432B2 (en) Organoids related to immunotherapy and methods of preparing and using the same
DeBord et al. The chick chorioallantoic membrane (CAM) as a versatile patient-derived xenograft (PDX) platform for precision medicine and preclinical research
Kageyama et al. Establishment of an orthotopic patient-derived xenograft mouse model using uveal melanoma hepatic metastasis
WO2023045494A1 (fr) Procédé de criblage de médicament et procédé de culture d'un modèle tridimensionnel de coupe de tumeur
AU2017306548A1 (en) Cancer modeling platforms and methods of using the same
CN109563486A (zh) 用于在癌症护理中做出患者特定的治疗决策的诊断方法
Neve et al. Investigation of brain tissue infiltration by medulloblastoma cells in an ex vivo model
US20190351076A1 (en) Tumor cell xenograft model in zebrafish, and methods of constructing and using the same
CN112592897A (zh) 一种肿瘤类器官的制备方法
Razmara et al. Tumor shedding and metastatic progression after tumor excision in patient-derived orthotopic xenograft models of triple-negative breast cancer
Koessinger et al. Quantitative in vivo bioluminescence imaging of orthotopic patient-derived glioblastoma xenografts
US20150377863A1 (en) Method for Testing the Response of Cells to Exposure with Therapeutics
US20070292901A1 (en) Methods and kits for evaluating and measuring the oncological status of tissue samples in three-dimensional physiological matrices
US7977041B2 (en) Methods and kits for testing the efficacy of therapeutic compounds and other therapies in a three-dimensional matrix with respect to tumorous cells and tissue
Biery et al. A protocol for the generation of treatment-naïve biopsy-derived diffuse intrinsic pontine glioma and diffuse midline glioma models
Johnson et al. Preclinical models and resources to facilitate basic science research on malignant mesothelioma–a review
CA2691044C (fr) Procedes et trousses pour tester l'efficacite de composes therapeutiques et d'autres therapies destines a des cellules et des tissus tumoraux dans une matrice tridimensionnelle
US8007991B2 (en) Three-dimensional physiological matrices for oncological testing, and methods for their production and use
WO2021159162A1 (fr) Alten
Ranjan et al. The chorioallantoic membrane xenograft assay as a reliable model for investigating the biology of breast cancer
Chowdhury et al. Ultrasound‐guided core needle biopsy for the diagnosis of rhabdomyosarcoma in childhood
CA2690751A1 (fr) Procedes et kits destines a evaluer et a mesurer le statut oncologique de prelevements de tissus dans des matrices physiologiques en trois dimensions
Conley et al. Ex vivo therapeutic screening of metastatic cSCC: A review of methodological considerations for clinical implementation
Greier et al. Optimizing culturing conditions in patient derived 3D primary slice cultures of head and neck cancer
Elena et al. Biobanks as an important tool in modern translational oncology

Legal Events

Date Code Title Description
EEER Examination request